CN100406038C - Method for preparing external-use Chinese medicine for treating ulcerative stomatitis - Google Patents
Method for preparing external-use Chinese medicine for treating ulcerative stomatitis Download PDFInfo
- Publication number
- CN100406038C CN100406038C CNB2006100497185A CN200610049718A CN100406038C CN 100406038 C CN100406038 C CN 100406038C CN B2006100497185 A CNB2006100497185 A CN B2006100497185A CN 200610049718 A CN200610049718 A CN 200610049718A CN 100406038 C CN100406038 C CN 100406038C
- Authority
- CN
- China
- Prior art keywords
- medicine
- tablet
- chinese medicine
- external use
- fructus evodiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 124
- 238000000034 method Methods 0.000 title claims abstract description 11
- 206010028034 Mouth ulceration Diseases 0.000 title abstract description 5
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 title abstract 3
- 201000008587 ulcerative stomatitis Diseases 0.000 title abstract 3
- 239000004744 fabric Substances 0.000 claims abstract description 9
- 239000000341 volatile oil Substances 0.000 claims description 18
- 208000002399 aphthous stomatitis Diseases 0.000 claims description 17
- 208000007117 Oral Ulcer Diseases 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000758 substrate Substances 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000741 silica gel Substances 0.000 claims description 12
- 229910002027 silica gel Inorganic materials 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000002481 ethanol extraction Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000005187 foaming Methods 0.000 claims description 5
- 230000004927 fusion Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 25
- 238000012360 testing method Methods 0.000 abstract description 19
- 230000036407 pain Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 2
- 241000758794 Asarum Species 0.000 abstract 1
- 208000038016 acute inflammation Diseases 0.000 abstract 1
- 230000006022 acute inflammation Effects 0.000 abstract 1
- 230000007969 cellular immunity Effects 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 230000006020 chronic inflammation Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 14
- 239000011248 coating agent Substances 0.000 description 14
- 238000000576 coating method Methods 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- 239000000546 pharmaceutical excipient Substances 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 10
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 8
- 230000035617 depilation Effects 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 208000028990 Skin injury Diseases 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 230000002489 hematologic effect Effects 0.000 description 4
- 231100001252 long-term toxicity Toxicity 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- ACVGWSKVRYFWRP-UHFFFAOYSA-N Rutecarpine Chemical compound C1=CC=C2C(=O)N(CCC=3C4=CC=CC=C4NC=33)C3=NC2=C1 ACVGWSKVRYFWRP-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003746 feather Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010004542 Bezoar Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- BCPAKGGXGLGKIO-UHFFFAOYSA-N Pseudorutaecarpin Natural products C1=CC=C2C(=O)N(CCC3=C4C5=CC=CC=C5N3)C4=NC2=C1 BCPAKGGXGLGKIO-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a method for preparing an external traditional Chinese medicine for treating ulcerative stomatitis. The external traditional Chinese medicine is prepared by combination of a tablet, non-woven rubber cloth and a PVC back lining, wherein the tablet is used as a raw material medicine; the tablet is mixed with base materials after being extracted and refined to produce a finished product by a hot melting method. The raw material medicine comprises asarum and medicinal evodia fruit, and the ratio of the weight of the raw material medicine to the weight of the base materials is 1:0.2 to 1. When the medicine which is prepared by the present invention, the skin around the umbilical part (Shenque point) is cleaned and wiped, and then, the non-woven rubber cloth and the PVC back lining are separated; the tablet is aligned to the umbilical part to be firmly pasted; one tablet is used once per day, and the tablet is convenient in use and carry. According to the research of pharmacology, the medicine which is prepared by the present invention has the strong functions of alleviating pain, obviously inhibiting acute and chronic inflammation reactions, enhancing the cellular immunity function and the humoral immunity function, and obviously treating ulcerative stomatitis of a testing rabbit; the medicine also has the advantage of no toxic or side effect.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of preparation method for the treatment of the Chinese medicine medicine for external use of oral ulcer.
Background technology
Oral ulcer, recurrent oral ulceration are modal diseases in the diseases of oral mucosa, the incidence rate height.It is steaming on accumulation of heat in the heart and spleen, the stomach-fire, hyperactivity of fire caused by deficiency of YIN that theory of Chinese medical science is recognized its pathogeny, steam in dispute institute extremely on scorchingly hot.The treatment by Chinese herbs oral ulcer is because of more difficult recurrence in back and toxic and side effects are less and well received.The Chinese medicine that is used for the treatment of oral ulcer at present is mainly decoction, membrane, powder, and weak point is all arranged.The fried trouble of decoction, volume is big, carries and takes inconvenience; Buccal bioadhesive tablet and powder, medicated powder directly are coated with spray or the medicine film is affixed on the oral ulcer place, bitter in the mouth behind the medicine dissolution and fiber crops, and medicine irritation ulcer easily causes pain, in use brings misery to the patient, the while medicine is easily washed away by saliva.Chinese patent literature discloses a kind of " Oral cavity healthy paste ", and usage is a course of treatment for plaster being affixed on the space between the eyebrows took off last 24 hour, reaches good therapeutic effect, but is that image appearance to patient damages outside the deficiency.
Summary of the invention
The objective of the invention is to carry and take inconvenience in order to solve Chinese medicine decoction, Chinese medicine buccal bioadhesive tablet and powder medication process Chinese medicine stimulate ulcer to cause pain, in use bring painful problem for the patient, provide a kind of medication convenient, medicine does not directly contact ulcer surface, and no pain has no side effect, therapeutic effect is good, and can not influence the preparation method of Chinese medicine medicine for external use of the treatment oral ulcer of image appearance.
Technical scheme of the present invention realizes in the following manner:
The step of method is as follows:
1. get Herba Asari, water vapour distillation gets volatile oil, adds the micropowder silica gel mixing of 0.5~2.5 times of amount of volatile oil volume, crosses 60~200 mesh sieves, and it is standby to make volatile oil micropowder silica gel mixture;
2. get Fructus Evodiae, add 40~90% ethanol extractions, filter while hot, decompression filtrate recycling ethanol is condensed into thick paste, and drying under reduced pressure was pulverized 60~200 mesh sieves, made the Fructus Evodiae extract powder, and was standby;
3. get substrate, after the heating in water bath fusion, be cooled to 45~65 ℃, insulation adds Fructus Evodiae extract powder, volatile oil micropowder silica gel mixture, stirs, (die throat diameter 13~17mm in the impouring mould, high by 2.0~3.5mm), cooling, the demoulding, get tablet, tablet is put in the PVC nib of foaming, be covered with non-woven rubberized fabric, get product.
Described Herba Asari: Fructus Evodiae=1~10.1~10.Herba Asari, Fructus Evodiae weight and substrate weight ratio are 1: 0.2~1.Substrate is Polyethylene Glycol.
Good effect of the present invention is:
1. medication is convenient, and therapeutic effect is good; Medication process Chinese medicine external used medicine does not directly contact ulcer surface, no pain; Be difficult for being washed away by saliva; Do not influence image appearance.
2. the transdermal test in vitro test shows that this product Chinese medicine can be stablized release in 24 hours, and duration of efficacy is long.
The specific embodiment:
The invention will be further described below in conjunction with embodiment:
Foundation of the present invention is: the main effective ingredient of Herba Asari is a volatile oil, has effects such as analgesia, antiinflammatory.The main effective ingredient of Fructus Evodiae is alkaloids compositions such as rutaecarpin, rutaecarpine, has effects such as antalgic and inflammation relieving, antiulcer.Molecular weight according to above-mentioned two effective constituents is less, fat-soluble stronger, the transdermal test in vitro test shows that skin is had permeability preferably, be fit to make the characteristics of transdermal absorption formulation, use modern extract refining and transdermal drag delivery, we are made the Chinese medicine medicine for external use that supplies umbilical region administration.Umbilicus (SHENQUE acupoint) is the remittance sea through gas, links to each other with the twelve regular channels, communicates with the vital organs of the human body.Dissect from modern medicine, umbilicus (SHENQUE acupoint) horny layer is thin, no subcutaneous fat, and fascia directly links to each other with peritoneum, the easy Transdermal absorption of medicine.In SHENQUE acupoint, through the infiltration and the defeated cloth of meridians, in penetrating with, the usefulness of performance medicine " return through " makes it to reach in the internal organs meridians by drug effect, and the sick institute of imbalance of YIN and YANG reaches the purpose of healing of canker sores.
The present invention has wind-dispelling heat-dissipating, and the effect of reducing swelling and alleviating pain is used for the treatment of card and belongs to the taste intrinsic heat, oral ulcer, recurrent oral ulceration due to heart-fire, the hyperactivity of deficient fire.Using method is external.Clean umbilical part (SHENQUE acupoint) surrounding skin, dry, then non-woven rubberized fabric is separated with the PVC sheet, tablet is aimed at umbilical part, paste firmly; An a slice, once-a-day.
The pharmacological action of this Chinese medicine medicine for external use:
This Chinese medicine medicine for external use of making a summary has significant therapeutical effect to the oral ulcer by the rabbit of acetic-acid induced; Significantly the pain response time appears in the mouse writhing number of times due to the minimizing glacial acetic acid, prolongation hot plate induced mice; Can significantly reduce by mice auricle swelling rate scorching due to the dimethylbenzene.
Results of pharmacodynamic test:
1, this Chinese medicine medicine for external use is to the therapeutical effect of tentative rabbit oral ulcer
Adopt acetic-acid induced rabbit oral ulcer model, the high, medium and low dosage of coating Chinese medicine medicine for external use is respectively 1.0,0.5,0.25g crude drug/kg, and the positive controls detoxicating tablet of cow-bezoar is irritated stomach; dosage 0.25g/kg; 4g/ of excipient matched group coating excipient, once a day, continuous six days.Before administration and after the experiment end, measure the oral ulcer area respectively, and observe the inflammatory congestion situation, define the level by following standard: 0 grade: do not have blush, no edema around the ulcer; 1 grade: blush, no edema are arranged around the ulcer slightly; 2 grades: blush, no edema are arranged around the ulcer; 3 grades: blush is arranged around the ulcer, edema is arranged, data see Table 1, table 2.
The influence of rabbit oral ulcer area due to the table 1 Chinese medicine medicine for external use Dichlorodiphenyl Acetate
Compare with the excipient matched group: *: P<0.05, * *: P<0.01, * * *: P<0.001.
The influence of rabbit oral ulcer inflammatory congestion due to the table 2 Chinese medicine medicine for external use Dichlorodiphenyl Acetate
Compare with the excipient matched group: *: P<0.05, * *: P<0.01.
The result: this Chinese medicine medicine for external use dosage has remarkable therapeutical effect greater than rabbit stomatocace due to 0.5g crude drug/kg Dichlorodiphenyl Acetate.
2, this Chinese medicine medicine for external use is studied the mice analgesic activity
2.1 the influence of this Chinese medicine medicine for external use Dichlorodiphenyl Acetate inducing mouse writhing response
Cause the mice pain model with acetic acid, apply that the high, medium and low dosage of this Chinese medicine medicine for external use is respectively 20,10,5g crude drug/kg, the positive controls aspirin is irritated stomach, dosage 200mg/kg, 0.5g/ of excipient matched group coating excipient, once a day, continuous six days.Behind last administration 1h, lumbar injection 0.6% glacial acetic acid 0.2ml/10g, that respectively organizes mice behind the record injection glacial acetic acid in the 20min turns round the body number of times, and data see Table 3.
Table 3 Chinese medicine medicine for external use Dichlorodiphenyl Acetate induced mice is turned round the influence of body number of times
Compare with the excipient matched group: * *: P<0.01, * * *: P<0.001.
The result: this Chinese medicine medicine for external use dosage can significantly reduce mouse writhing number of times due to the glacial acetic acid greater than 5.0g crude drug/kg.
2.2 this Chinese medicine medicine for external use causes the influence in pain response time to thermostimulation
Adopt the mice hot plate method, apply that the high, medium and low dosage of this Chinese medicine medicine for external use is respectively 20,10,5g crude drug/kg, the positive controls aspirin is irritated stomach, dosage 200mg/kg, excipient matched group coating excipient 0.5g/ only, once a day, continuous six days.Carry out the test of mice hot plate method behind last administration 1h, data see Table 4.
The influence in pain response time appears in table 4 Chinese medicine medicine for external use to the mice hot plate
Compare with the excipient matched group: * *: P<0.01, *: P<0.05.
The result: this Chinese medicine medicine for external use dosage can significant prolongation hot plate induced mice the pain response time occur greater than 10.0g crude drug/kg.
3. this Chinese medicine medicine for external use antiinflammatory action
This Chinese medicine medicine for external use is to the antiinflammatory action of mouse ear caused by dimethylbenzene xylene inflammation
Adopt mice caused by dimethylbenzene xylene auricle edema model, apply that the high, medium and low dosage of this Chinese medicine medicine for external use is respectively 20,10,5g crude drug/kg, the positive controls aspirin is irritated stomach, dosage 200mg/kg, 0.5g/ of excipient matched group coating excipient, once a day, continuous six days.Behind last administration 1h, carry out the scorching test of mouse ear caused by dimethylbenzene xylene, data see Table 5.
The influence of table 5 Chinese medicine medicine for external use xylol induced mice auricle edema
Compare with the excipient matched group: *: P<0.05, * *: P<0.01, * * *: P<0.001.
The result: this Chinese medicine medicine for external use dosage can significantly reduce dimethylbenzene induced mice auricle swelling degree and corresponding inflammation weightening finish percentage rate greater than 5.0g crude drug/kg.
The toxicology test result:
1. acute toxicity test
Give skin complete and skin injury (the depilation back with slight oozing of blood degree of being, is caused skin injury with the rubber skin that rubs) rabbit, coating Chinese medicine medicine for external use 30g crude drug/kg, continuous 3 times, each 4 hours at interval, accumulated dose was 90.0g crude drug/kg.Remove medicine with warm water in coating first after 24 hours, observe every day, continuous 14 days.Result: relatively do not have significant difference before the index of reflection whole body poisoning symptoms such as the body weight of two groups of rabbit, skin, hair, eyes, activity, breathing, muscular tension, feces situation and the administration, there is no the overt toxicity reaction, none animal dead.
2. long term toxicity test
(the depilation back is with the rubber skin that rubs to give skin complete and skin injury, with slight oozing of blood degree of being, cause skin injury) rabbit, coating Chinese medicine medicine for external use, twice on the one, high and low dose is respectively 40.0,4.0g crude drug/kg/ days, blank substrate matched group, give skin complete and skin injury (the depilation back with slight oozing of blood degree of being, is caused skin injury with the rubber skin that rubs) the blank substrate of rabbit coating equivalent 6.67g/kg/ days, removed medicine or blank substrate with warm water in 4 hours behind the coating, observe every day, successive administration 28 days, drug withdrawal 14 days is as convalescent period.The result is as follows for the every observation of administration phase and convalescent period, detection index gained:
(1) 6 treated animals of being tested do not have death in administration phase and convalescent period.
(2) all no abnormal variation of each the dosage treated animal activity in convalescent period, hair color, food-intake after administration phase and drug withdrawal.
(3) body weight change: each dosage treated animal is steady in administration phase and drug withdrawal convalescent period body weight gain, compares no significant difference with blank matrix group, and data see Table 7.
Table 7 Chinese medicine medicine for external use rabbit skin long term toxicity test body weight change (kg, x ± SD)
Annotate: the 0th day~28 days number of animals n of administration are respectively each 4 of male and female, and drug withdrawal convalescent period n is respectively each 1 of male and female.
(4) hematological indices: index such as leukocyte count and classification after 14 days, erythrocyte, platelet count, clotting time all fluctuates in normal range after each dosage group medication 28 days and the drug withdrawal, with before the medication or with blank substrate matched group identical administration phase no significant difference (P>0.05) relatively, data see Table 8.
Table 8 Chinese medicine medicine for external use rabbit skin long term toxicity test hematological indices (x ± SD)
Annotate: 1. every hematological indices all fluctuates in normal range after the administration;
2. the 0th day~28 days number of animals n of administration are respectively 8, and drug withdrawal convalescent period number of animals n is 2.
(continuous table 8)
Annotate: 1. every hematological indices all fluctuates in normal range after the administration;
2. the 0th day~28 days number of animals n of administration are respectively 8, and drug withdrawal convalescent period n is 2.
(5) blood biochemical is learned: comprise indexs such as ALT, AST, TBIL, TP, ALB, GLB, ALP, CHO, BUN, CR, GLU, CK, TG, each treated animal before medication phase and convalescent period and administration or with the blank substrate matched group same period of no significant difference (P>0.05) relatively, and in fluctuation normal range, data see Table 9.
Table 9 Chinese medicine medicine for external use rabbit skin long term toxicity test changes of biochemical indexes (x ± SD)
Annotate: 1. every biochemical indexes all fluctuates in normal range after the administration;
2. the 0th day~28 days animal n numbers of administration are 8, and drug withdrawal convalescent period n is 2.
(6) organ coefficient: administration is after 28 days, and numerical value is all approaching between each group of organ coefficient, does not relatively have significant difference with blank substrate matched group.
(7) histopathological examination: perusal and check pathological section show, administration after 28 days internal organs such as each dosage group man Cor Leporis, lung, liver,spleen,kidney, brain, hypophysis cerebri, thyroid, adrenal gland, thymus, stomach, duodenum, bladder, testis, ovary, epididymis, uterus, breastbone, skin there is no unusually.
The result shows that damaged skin and the continuous skin of intact skin rabbit give Chinese medicine medicine for external use 40.0g crude drug/kg and 4.0g crude drug/kg did not have overt toxicity to rabbit in 28 days.
The test of 3 skin irritations
3.1 the skin irritation of single-dose test
Rabbit skin pretreatment: lost hair or feathers the about 150cm of depilation scope with 8% sodium sulfide in the spinal column both sides in preceding 24 hours in test
2/ only (be equivalent to approximately body surface area 10%).Reuse rubber friction skin after wherein damaged skin group rabbit loses hair or feathers is with slight oozing of blood degree of being.Give back rabbit left side depilation district's skin (complete or damaged) coating Chinese medicine medicine for external use 6.0g crude drug/kg, the right side is coated with blank substrate 6.0g/kg, remove medicine and blank substrate with warm water in coating after 6 hours, observe the reaction that 1h, 24h, 48h and 72h smear the position then respectively.Standards of grading see Table 10, table 11.The result: each skin of organizing rabbit does not all have erythema, edema phenomenon (score value is 0), and hair, outward appearance, activity, food-intake, eyes are also all no abnormal.Single is given Chinese medicine medicine for external use 6.0g/kg to rabbit intact skin and the equal nonirritant of damaged skin.
The skin irritation test standard of table 10 rabbit
Table 11 skin irritation intensity evaluation standard
3.2 the skin irritation of multiple dosing test
Rabbit skin pretreatment: lost hair or feathers the about 150cm of depilation scope with 8% sodium sulfide in the spinal column both sides in preceding 24 hours in test
2/ only (be equivalent to approximately body surface area 10%).Give back rabbit left side depilation district's skin (complete or damaged) coating Chinese medicine medicine for external use 6.0g crude drug/kg, the right side is coated with blank substrate 6.0g/kg, the damaged skin method for making for the depilation back with the rubber skin that rubs, with slight oozing of blood degree of being, cause skin injury.Every day, coating was 1 time, continuous 7 days, observed 3 days after the drug withdrawal.Standards of grading see Table 10, table 11.The result: the skin irritation test mean scores of complete sum damaged skin administration group rabbit is 0.17, less than slight zest evaluation criterion value 0.5, so think that Chinese medicine medicine for external use multiple dosing does not all have obvious irritation to intact skin and damaged skin.
Embodiment 1:
1, get Herba Asari 580g, add 8 times of water gagings and soaked 1 hour, water vapour distillation 3 hours gets volatile oil, adds the micropowder silica gel mixing of 1 times of amount of volatile oil volume, crosses 100 mesh sieves, and is standby.
2, get Fructus Evodiae 580g, add 80% ethanol extraction 2 times, each 2 hours, filter while hot, decompression filtrate recycling ethanol is condensed into thick paste, and drying under reduced pressure was pulverized 100 mesh sieves, and was standby.
3, taking polyethylene glycol 374.6g after the heating in water bath fusion, is cooled to 50~55 ℃, insulation adds Fructus Evodiae extract powder, volatile oil micropowder silica gel mixture, stirs, (die throat diameter 15mm in the impouring mould, high 2.5mm), cooling, the demoulding, get tablet, tablet is put in the PVC nib of foaming, be covered with non-woven rubberized fabric, get product.
Embodiment 2:
1, get Herba Asari 870g, add 8 times of water gagings and soaked 1 hour, water vapour distillation 3 hours gets volatile oil, adds the micropowder silica gel mixing of 2.0 times of amounts of volatile oil volume, crosses 120 mesh sieves, and is standby.
2, get Fructus Evodiae 290g, add 70% ethanol extraction 2 times, each 2 hours, filter while hot, decompression filtrate recycling ethanol is condensed into thick paste, and drying under reduced pressure was pulverized 120 mesh sieves, and was standby.
3, taking polyethylene glycol 442.5g after the heating in water bath fusion, is cooled to 50~55 ℃, insulation adds Fructus Evodiae extract powder, volatile oil micropowder silica gel mixture, stirs, (die throat diameter 15mm in the impouring mould, high 2.5mm), cooling, the demoulding, get tablet, tablet is put in the PVC nib of foaming, be covered with non-woven rubberized fabric, get product.
Embodiment 3:
1, get Herba Asari 290g, add 8 times of water gagings and soaked 1 hour, water vapour distillation 3 hours gets volatile oil, adds the micropowder silica gel mixing of 0.8 times of amount of volatile oil volume, crosses 100 mesh sieves, and is standby.
2, get Fructus Evodiae 870g, add 60% ethanol extraction 2 times, each 2 hours, filter while hot, decompression filtrate recycling ethanol is condensed into thick paste, and drying under reduced pressure was pulverized 100 mesh sieves, and was standby.
3, taking polyethylene glycol 287.0g after the heating in water bath fusion, is cooled to 50~55 ℃, insulation adds Fructus Evodiae extract powder, volatile oil micropowder silica gel mixture, stirs, (die throat diameter 15mm in the impouring mould, high 2.5mm), cooling, the demoulding, get tablet, tablet is put in the PVC nib of foaming, be covered with non-woven rubberized fabric, get product.
Claims (2)
1. preparation method for the treatment of the Chinese medicine medicine for external use of oral ulcer is characterized in that the step of method is as follows:
1) get Herba Asari, water vapour distillation gets volatile oil, adds the micropowder silica gel mixing of 0.5~2.5 times of amount of volatile oil volume, crosses 60~200 mesh sieves, and it is standby to make volatile oil micropowder silica gel mixture;
2), get Fructus Evodiae, add 40~90% ethanol extractions, filter while hot, decompression filtrate recycling ethanol is condensed into thick paste, drying under reduced pressure was pulverized 60~200 mesh sieves, made the Fructus Evodiae extract powder, and was standby;
3), get substrate, after the heating in water bath fusion, be cooled to 45~65 ℃, insulation adds Fructus Evodiae extract powder, volatile oil micropowder silica gel mixture, stir, cool off in the impouring mould, the demoulding gets tablet, tablet is put in the PVC nib of foaming, be covered with non-woven rubberized fabric, get product
Described substrate is Polyethylene Glycol, Herba Asari: Fructus Evodiae=1~10: 1~10, and Herba Asari, Fructus Evodiae weight and substrate weight ratio are 1: 0.2~1.
2. a kind of preparation method for the treatment of the Chinese medicine medicine for external use of oral ulcer according to claim 1 is characterized in that the nib of described mould is diameter 13~17mm, and height is 2.0~3.5mm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100497185A CN100406038C (en) | 2006-03-06 | 2006-03-06 | Method for preparing external-use Chinese medicine for treating ulcerative stomatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100497185A CN100406038C (en) | 2006-03-06 | 2006-03-06 | Method for preparing external-use Chinese medicine for treating ulcerative stomatitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1850201A CN1850201A (en) | 2006-10-25 |
CN100406038C true CN100406038C (en) | 2008-07-30 |
Family
ID=37131713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100497185A Expired - Fee Related CN100406038C (en) | 2006-03-06 | 2006-03-06 | Method for preparing external-use Chinese medicine for treating ulcerative stomatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100406038C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488774B (en) * | 2011-12-22 | 2014-03-12 | 马贵廷 | Chinese medicinal powder for treating canker sore and preparation method thereof |
CN112791133B (en) * | 2021-02-08 | 2022-03-25 | 复旦大学附属金山医院(上海市金山区核化伤害应急救治中心、上海市金山区眼病防治所) | Traditional Chinese medicine composition for treating chronic postoperative pain and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104512A (en) * | 1993-12-28 | 1995-07-05 | 西南民族学院 | Medicine powder for aphtha |
-
2006
- 2006-03-06 CN CNB2006100497185A patent/CN100406038C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104512A (en) * | 1993-12-28 | 1995-07-05 | 西南民族学院 | Medicine powder for aphtha |
Non-Patent Citations (4)
Title |
---|
口腔溃疡. 杨晨武.健康生活,第12期. 2005 |
口腔溃疡. 杨晨武.健康生活,第12期. 2005 * |
口腔溃疡有哪些外治方法. 中医杂志,第43卷第11期. 2002 |
口腔溃疡有哪些外治方法. 中医杂志,第43卷第11期. 2002 * |
Also Published As
Publication number | Publication date |
---|---|
CN1850201A (en) | 2006-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169928B (en) | Externally applied traditional Chinese medicine composition for treating dysmenorrhea, as well as preparation method and application thereof | |
CN1947739B (en) | Traditional Chinese medicine composition for treating dermal titillation and chronic eczema and its preparation method | |
CN103041173A (en) | Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof | |
CN101607051B (en) | Traditional Chinese medicine composition for losing weight and preparation method thereof | |
CN101912527A (en) | Medicinal preparation for curing wind chill blockage disease and preparation method thereof | |
CN100406038C (en) | Method for preparing external-use Chinese medicine for treating ulcerative stomatitis | |
CN104587302A (en) | Traditional Chinese medicine preparation for treating acute appendicitis | |
CN101991811B (en) | Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof | |
CN102430013A (en) | Chinese medicine for treating vitiligo | |
CN109464583A (en) | A kind of anti-inflammatory Chinese traditional composition for animals and its preparation method and application | |
CN105343498A (en) | Traditional Chinese medicine preparation for moistening lungs and preparation method and uses thereof | |
CN102038778A (en) | Chinese medicinal composition with effects of relaxing meridians, activating collaterals, expelling wind and removing dampness and preparation method thereof | |
CN107496525A (en) | A kind of Chinese medicine composition for treating cancer pain disease and its application | |
CN108403869B (en) | Traditional Chinese medicine composition for removing chloasma and preparation method thereof | |
CN1850200A (en) | Formula of external-use Chinese medicine for treating ulcerative stomatitis | |
JP5265347B2 (en) | Use of konjac and its extract in formulating pharmaceuticals for the treatment of acute and chronic bronchitis | |
CN102145152B (en) | Tradition Chinese medicinal preparation for treating cyclomastopathy and preparation method thereof | |
CN101822741B (en) | Oral ulcer healing membrane with traditional Chinese medicine bioadhesive one-way medicine release | |
CN101632756A (en) | Traditional Chinese medicine for treating malignant tumours and preparation method thereof | |
CN110507712A (en) | A kind of arthritic Radix Pulsatillae extract of external curing and preparation method thereof | |
CN103316106A (en) | Danshan fat reducing granules and preparation method thereof | |
CN102973698B (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
CN108434299B (en) | Pharmaceutical composition for treating scapulohumeral periarthritis and preparation method and spray thereof | |
CN102973547B (en) | Traditional Chinese medicine patch for treating digestive system diseases | |
CN104784558A (en) | Traditional Chinese medicine composition for treating recurrent oral ulceration and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080730 Termination date: 20140306 |